Literature DB >> 18297104

Long-term nitric oxide deficiency causes muscarinic supersensitivity and reduces beta(3)-adrenoceptor-mediated relaxation, causing rat detrusor overactivity.

F Z T Mónica1, A A O Bricola, F R Báu, L L Lopes Freitas, S A Teixeira, M N Muscará, F M F Abdalla, C S Porto, G De Nucci, A Zanesco, E Antunes.   

Abstract

BACKGROUND AND
PURPOSE: Overactive bladder is a complex and widely prevalent condition, but little is known about its physiopathology. We have carried out morphological, biochemical and functional assays to investigate the effects of long-term nitric oxide (NO) deficiency on muscarinic receptor and beta-adrenoceptor modulation leading to overactivity of rat detrusor muscle. EXPERIMENTAL APPROACH: Male Wistar rats received N(omega)-nitro-L-arginine methyl ester (L-NAME) in drinking water for 7-30 days. Functional responses to muscarinic and beta-adrenoceptor agonists were measured in detrusor smooth muscle (DSM) strips in Krebs-Henseleit solution. Measurements of [(3)H]inositol phosphate, NO synthase (NOS) activity, [(3)H]quinuclidinyl benzilate ([(3)H]QNB) binding and bladder morphology were also performed. KEY
RESULTS: Long-term L-NAME treatment significantly increased carbachol-induced DSM contractile responses after 15 and 30 days; relaxing responses to the beta(3)-adrenoceptor agonist BRL 37-344 were significantly reduced at 30 days. Constitutive NOS activity in bladder was reduced by 86% after 7 days and maintained up to 30 days of L-NAME treatment. Carbachol increased sixfold the [(3)H]inositol phosphate in bladder tissue from rats treated with L-NAME. [(3)H]QNB was bound with an apparent K(D) twofold higher in bladder membranes after L-NAME treatment compared with that in control. No morphological alterations in DSM were found. CONCLUSIONS AND IMPLICATIONS: Long-term NO deficiency increased rat DSM contractile responses to a muscarinic agonist, accompanied by significantly enhanced K(D) values for muscarinic receptors and [(3)H]inositol phosphate accumulation in bladder. This supersensitivity for muscarinic agonists along with reductions of beta(3)-adrenoceptor-mediated relaxations indicated that overactive DSM resulted from chronic NO deficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18297104      PMCID: PMC2438257          DOI: 10.1038/bjp.2008.39

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  50 in total

1.  Pharmacological characterization of beta-adrenoceptors mediating relaxation of the rat urinary bladder in vitro.

Authors:  P A Longhurst; M Levendusky
Journal:  Br J Pharmacol       Date:  1999-08       Impact factor: 8.739

Review 2.  Muscarinic receptor subtypes modulating smooth muscle contractility in the urinary bladder.

Authors:  S S Hegde; R M Eglen
Journal:  Life Sci       Date:  1999       Impact factor: 5.037

Review 3.  Chronic nitric oxide inhibition model six years on.

Authors:  R Zatz; C Baylis
Journal:  Hypertension       Date:  1998-12       Impact factor: 10.190

4.  Human idiopathic and neurogenic overactive bladders and the role of M2 muscarinic receptors in contraction.

Authors:  Laurie A Stevens; Christopher R Chapple; Russ Chess-Williams
Journal:  Eur Urol       Date:  2006-11-15       Impact factor: 20.096

5.  Beta 3-adrenoceptor stimulation induces vasorelaxation mediated essentially by endothelium-derived nitric oxide in rat thoracic aorta.

Authors:  J N Trochu; V Leblais; Y Rautureau; F Bévérelli; H Le Marec; A Berdeaux; C Gauthier
Journal:  Br J Pharmacol       Date:  1999-09       Impact factor: 8.739

6.  Long-term nitric oxide inhibition and chronotropic responses in rat isolated right atria.

Authors:  S R Riado; A Zanesco; L A Barker; I M De Luca; E Antunes; G De Nucci
Journal:  Hypertension       Date:  1999-10       Impact factor: 10.190

7.  Cystometric findings in mice lacking muscarinic M2 or M3 receptors.

Authors:  Yasuhiko Igawa; Xiaoyang Zhang; Osamu Nishizawa; Masaomi Umeda; Atsuko Iwata; Makoto M Taketo; Toshiya Manabe; Minoru Matsui; Karl-Erik Andersson
Journal:  J Urol       Date:  2004-12       Impact factor: 7.450

8.  Functional role of M2 and M3 muscarinic receptors in the urinary bladder of rats in vitro and in vivo.

Authors:  S S Hegde; A Choppin; D Bonhaus; S Briaud; M Loeb; T M Moy; D Loury; R M Eglen
Journal:  Br J Pharmacol       Date:  1997-04       Impact factor: 8.739

9.  Species differences in the distribution of beta-adrenoceptor subtypes in bladder smooth muscle.

Authors:  Y Yamazaki; H Takeda; M Akahane; Y Igawa; O Nishizawa; Y Ajisawa
Journal:  Br J Pharmacol       Date:  1998-06       Impact factor: 8.739

10.  The negative inotropic effect of beta3-adrenoceptor stimulation is mediated by activation of a nitric oxide synthase pathway in human ventricle.

Authors:  C Gauthier; V Leblais; L Kobzik; J N Trochu; N Khandoudi; A Bril; J L Balligand; H Le Marec
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

View more
  12 in total

Review 1.  Stimulators and activators of soluble guanylate cyclase for urogenital disorders.

Authors:  Fabiola Z Mónica; Edson Antunes
Journal:  Nat Rev Urol       Date:  2017-11-14       Impact factor: 14.432

2.  Does hypercholesterolemia affect the relaxation of the detrusor smooth muscle in rats? In vitro and in vivo studies.

Authors:  Sibel Bayrak; Zeynep Dicle Balkanci; Bilge Pehlivanoğlu; İsmail Karabulut; Serkan Karaismailoğlu; Ayşen Erdem
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2014-10-26       Impact factor: 3.000

3.  Urinary dysfunction in transgenic sickle cell mice: model of idiopathic overactive bladder syndrome.

Authors:  Serkan Karakus; Uzoma A Anele; Fábio H Silva; Biljana Musicki; Arthur L Burnett
Journal:  Am J Physiol Renal Physiol       Date:  2019-06-19

4.  cAMP-dependent regulation of RhoA/Rho-kinase attenuates detrusor overactivity in a novel mouse experimental model.

Authors:  William Akakpo; Biljana Musicki; Arthur L Burnett
Journal:  BJU Int       Date:  2017-04-11       Impact factor: 5.588

5.  NO-Releasing Nanoparticles Ameliorate Detrusor Overactivity in Transgenic Sickle Cell Mice via Restored NO/ROCK Signaling.

Authors:  Serkan Karakus; Biljana Musicki; Mahantesh S Navati; Joel M Friedman; Kelvin P Davies; Arthur L Burnett
Journal:  J Pharmacol Exp Ther       Date:  2020-03-06       Impact factor: 4.030

6.  Proteomic Analysis of Urothelium of Rats with Detrusor Overactivity Induced by Bladder Outlet Obstruction.

Authors:  Edmond Changkyun Park; Jae Sung Lim; Seung Il Kim; Sang-Yeop Lee; Yu-Kyung Tak; Chi-Won Choi; Sungho Yun; Joohyun Park; Minji Lee; Hyo Kyun Chung; Koon Soon Kim; Yong Gil Na; Ju Hyun Shin; Gun-Hwa Kim
Journal:  Mol Cell Proteomics       Date:  2018-02-01       Impact factor: 5.911

7.  Human Urinary Bladder Strip Relaxation by the β-Adrenoceptor Agonist Isoprenaline: Methodological Considerations and Effects of Gender and Age.

Authors:  Tim Schneider; Charlotte Fetscher; Martin C Michel
Journal:  Front Pharmacol       Date:  2011-02-25       Impact factor: 5.810

8.  Effects of nitric oxide inhibitors in mice with bladder outlet obstruction.

Authors:  Marcy Lancia Pereira; Carlos Arturo Levi D'ancona; Julio Alejandro Rojas-Moscoso; Antonio Celso Saragossa Ramos; Fabiola Zakia Monica; Edson Antunes
Journal:  Int Braz J Urol       Date:  2017 Mar-Apr       Impact factor: 1.541

9.  Association of insulin resistance with overactive bladder in female patients.

Authors:  Hakki Uzun; Adnan Yilmaz; Ahu Kemik; Orhan Unal Zorba; Mehmet Kalkan
Journal:  Int Neurourol J       Date:  2012-12-31       Impact factor: 2.835

10.  Increased bladder wall thickness in diabetic and nondiabetic women with overactive bladder.

Authors:  Hakkı Uzun; Sabri Ogullar; Serap Baydur Sahin; Orhan Ünal Zorba; Görkem Akça; Fatih Sümer; Ulkü Mete Güney; Gülşah Balık
Journal:  Int Neurourol J       Date:  2013-06-30       Impact factor: 2.835

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.